Luyan Pharma Co.,Ltd. (SHE:002788)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Wholesale of Medicine	19.11B	18.59B	18.25B	18.19B	16.50B
Wholesale of Medicine Growth	2.84%	1.85%	0.31%	10.28%	13.15%
Pharmaceutical Retail	1.52B	1.19B	1.04B	847.42M	719.00M
Pharmaceutical Retail Growth	27.14%	14.46%	23.02%	17.86%	0.30%
Pharmaceutical Industry	558.61M	618.17M	493.90M	366.70M	293.18M
Pharmaceutical Industry Growth	-9.64%	25.16%	34.69%	25.08%	-
Other	57.35M	72.73M	60.56M	56.58M	37.16M
Other Growth	-21.15%	20.10%	7.03%	52.24%	-84.51%
Total	21.25B	20.47B	19.85B	19.46B	17.55B
Total Growth	3.79%	3.15%	1.97%	10.93%	12.94%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	21.25B	20.47B	19.85B	19.46B	17.55B
China Growth	3.79%	3.15%	1.97%	10.93%	12.94%
Total	21.25B	20.47B	19.85B	19.46B	17.55B
Total Growth	3.79%	3.15%	1.97%	10.93%	12.94%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 13, 2026

Data Sources Report a data error